Form 4: Definitive Healthcare CFO Heller Granted 733,301 RSUs

Definitive Healthcare's Chief Financial Officer, Casey Heller, was granted 733,301 restricted stock units, vesting over approximately four years.

Summary

• Casey Heller, Chief Financial Officer of Definitive Healthcare Corp. (DH), was granted 733,301 restricted stock units (RSUs) on February 24, 2026.
• Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• The RSUs will vest over approximately four years, with 25% vesting on March 1, 2027, followed by 6.25% vesting every three months thereafter over the subsequent three years.
• Vesting is contingent upon Heller's continued service with Definitive Healthcare Corp. through each vesting date.
• Following this transaction, Heller beneficially owns 2,007,322 shares of Class A Common Stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for corporate governance and executive retention, as it aligns the CFO's long-term interests with shareholder value through equity incentives, though it does not directly reflect operational performance.

Positives

• The grant of 733,301 restricted stock units to the Chief Financial Officer aligns management's long-term interests with shareholder value.
• The multi-year vesting schedule, extending over approximately four years, serves as a strong incentive for executive retention.

Negatives

• The compensation is in the form of restricted stock units, meaning there is no immediate cash compensation or direct stock purchase by the executive.

Risks

• The vesting of the restricted stock units is subject to the reporting person's continued service with the Issuer, meaning the shares are not guaranteed if employment ceases before vesting dates.

Future Outlook

The RSU grant with a multi-year vesting schedule indicates a long-term commitment to the company's future performance and executive retention, aligning the CFO's incentives with the company's strategic goals.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of executive compensation in the healthcare technology sector, aligning executive incentives with long-term company performance and shareholder value. This practice is consistent with industry standards for attracting and retaining key talent.

Comparison to Industry Standards

• RSU grants with multi-year vesting schedules are a standard compensation practice for C-suite executives in the technology and healthcare sectors, similar to grants observed at companies like Veeva Systems or IQVIA.
• The vesting schedule, with an initial cliff and subsequent quarterly vesting, is a common structure designed to promote long-term retention and performance alignment with company objectives.

Stakeholder Impact

• Shareholders: Potential long-term value creation through enhanced executive alignment and retention; potential future dilution from the issuance of shares upon RSU vesting.
• Employees: Signals commitment to executive talent, which can positively influence overall employee morale and perception of company stability.

Next Steps

• Continued service of Casey Heller with Definitive Healthcare Corp. to fulfill vesting conditions.
• Vesting of 25% of the granted RSUs on March 1, 2027.
• Subsequent quarterly vesting of 6.25% of the RSUs over the following three years.

Key Dates

Recommendation

The RSU grant to the CFO is a standard executive compensation practice aimed at aligning management's interests with long-term shareholder value and retaining key talent. While positive for governance, it does not provide new information on operational performance or financial results that would significantly alter an investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Definitive Healthcare, DH, Casey Heller, CFO, Restricted Stock Units, RSU, Stock Grant, Executive Compensation, Insider Transaction, Form 4